Archives: Agenda

• How to format Global Import Documentation: Master FDA filing requirements for APIs and clinical materials to help eliminate border holds caused by missing IND numbers, label mismatches, and improper valuation
• How to resolve a notice of detention: Navigate the response process, coordinate with FDA investigators to address deficiencies, and help avoid formal product refusals or delays to clinical trials
• How to Protect US Pipelines from Global Friction: Secure US-bound supply chains by managing extended lead times and maintaining compliance through changing regulatory and trade environments

• What has driven China’s remarkable shift from fast follower to global innovator in drug development and clinical trials?
• Regulatory reform and aligned incentives as the engine behind “China Speed” and the growth of China’s clinical trial ecosystem
• How can the US clinical trials industry use local partnerships and smart planning to navigate China’s rapidly growing R&D sector and unlock new opportunities for global success?
• What China’s growing role in global licensing and partnering means for R&D strategy, market entry and cross-border collaboration

• How to identify where NDCs are hardcoded in your clinical packaging, labeling, and warehouse management systems
• The Burden of Dual-Format Management: Strategies for handling the messy transition period where both 10 – and 12-digit codes will coexist in the market.
• A step-by-step checklist to align regulatory, clinical operations, and IT partners for a seamless system overhaul

🏆 PRIZE DRAW: Visit our exhibitors’ booths throughout the day and collect stamps to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

• Uncovering Hidden Risks: Spotting underestimated supply bottlenecks from complex protocols and comparator sourcing to global regulatory compliance that threaten trial timelines
• Protecting Patient Continuity: Understanding the real-world operational impact on patient treatment and trial viability when clinical supply chains fail
• Early Strategic Planning: Applying proactive forecasting and robust sourcing frameworks early to ensure seamless trial execution and protect commercial goals.

• Simulating Disruptions: Testing the impact of sudden supplier failures, customs delays, or enrollment spikes virtually before they disrupt real-world trials
• Optimizing Budgets & Inventory: Running predictive scenarios to find the perfect balance between overproducing expensive investigational drugs and risking stockouts
• Driving Aggressive Lead-Time Reduction

• How to move beyond qualitative promises by building a hard-data business case that measures time-to-market acceleration, waste reduction, and compliance risk avoidance
• Key strategies for aligning clinical operations, IT, and fi nance around shared digital goals, addressing operational resistance, and justifying initial capital expenditure
• Actionable frameworks for transitioning successful digital supply chain proofs-of-concept into fully integrated, enterprise-wide production workflows without disrupting ongoing trials